A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of LG00034053 in Patients With Knee OA

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
This study is a multi-center, randomized, placebo-controlled, double-blind clinical study, consisting of Part 1 (Phase 1b) in a sequential, dose-escalating design and Part 2 (Phase 2) in a parallel design.
Epistemonikos ID: 1173791a16cb2507d8b609a862c5f1ee073427f2
First added on: Dec 20, 2022